Antipsychotic Medication Use in Pregnancy and Risk of Maternal and Neonatal Metabolic Complications
In this retrospective study of Taiwanese women using antipsychotic medications there was no observed increase in risk of metabolic complications.
In this retrospective study of Taiwanese women using antipsychotic medications there was no observed increase in risk of metabolic complications.
Women undergoing infertility treatment, as well as women who conceived after infertility, experienced significant levels of distress as a result of the COVID-10 pandemic.
Every week we review the most recent publications in women’s mental health.
Two studies - one using neuropsychological assessments, another examining performance on standardized testing - show no association between prenatal antipsychotic exposure and neurodevelopmental outcomes.
Every week we review the most recent publications in women’s mental health.
Dr. Lee S. Cohen, Director of the Ammon-Pinizzotto Center for Women's Mental Health at Massachusetts General Hospital, recently shared his insights on the long-term behavioral follow-up of children exposed to mood stabilizers and antidepressants with Ob.Gyn News on August 16,
Every week we review the most recent publications in women’s mental health.
Consistent with other studies, including a large meta-analysis, this study indicates no increased risk of ADHD in offspring following prenatal exposure to antidepressants.
This meta-analysis is reassuring regarding risk for malformations in children exposed prenatally to oxcarbazepine; however, we still need more data to fully assess reproductive safety.
Every week we review the most recent publications in women’s mental health.